Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Dinara Ryspayeva

1PUBLICATIONS

16CO-AUTHORS

Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Jul 19, 2024

Phase II Trial of HER-Vaxx, a B-cell Peptide-Based Vaccine, in HER2-Overexpressing Advanced Gastric Cancer Patients Under Platinum-Based Chemotherapy (HERIZON).

Joshua Tobias, Marina Maglakelidze, Zoran Andrić

Pageof 1

Frequent Collaborators

1 joint publications

Joshua Tobias

1 joint publications

Marina Maglakelidze

1 joint publications

Zoran Andrić

1 joint publications

Iurie Bulat

1 joint publications

Ivan Nikolić

1 joint publications

Zoran Petrović

1 joint publications

Tanuj Chawla

1 joint publications

Rajnish Nagarkar

1 joint publications

Erika Garner-Spitzer

1 joint publications

Christoph C Zielinski

Frequent Collaborators

1 joint publications

Joshua Tobias

1 joint publications

Marina Maglakelidze

1 joint publications

Zoran Andrić

1 joint publications

Iurie Bulat

Top Related Videos

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on : Dec 11, 2017

See more related videos

Top Related Videos

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on : Dec 11, 2017

See more related videos